Home
1 888 2 DONATE(1 888 236-6283)
CLINICSDONORSVOLUNTEERSHOSPITALSMEDIA ROOMABOUT USCAREERS
Find a Clinic:  search Search this site:  search
Book an appointment
Home > What Should I Know? > R&D
Facebook youTube Twitter flickr
Why Should I Donate?
Who Needs Blood?
Can I donate?
Basic Eligibility
Donor Questionnaire
Malaria policy
Donation Date Calculator
American Sign Language
MSM
What Can I Donate?
Types of Donations
Blood
Plasma & Platelets
Stem Cells
Financial Gifts
Blood for Research
How Can I Get Involved?
In My Community
Send an e-card
Public Involvement
Volunteers
Partners for Life
What's Your Type
Sign Up to Learn More
OneMatch
Young Blood For Life
Assignment Saving Lives
National Blood Donor Week
What Should I Know?
FAQs
Pandemic Preparedness
Safety and Testing
Research & Development
West Nile Virus (WNV)
Transfusion Related Acute Lung Injury (TRALI)
vCJD Travel Deferral
Blackboard
Forms
Become a Volunteer
New Donor Form
Change Your Address
Join OneMatch
Become a Partner for Life Organization
Become a Partner for Life Member
Join Ready, Set... Give!
Donor Experience Survey
Hospitals
Customer Service
Circular of Information
Customer Letters
Plasma Protein Products
TransfusionMedicine.ca
Hospital Customer Forms
Resource Library
OneMatch Documents
Adverse Events
Diagnostic Services
 

Bayer Grant Results for 2000

Principal Investigator Grant Title Total Amount Awarded Comments
André M. Cantin Alpha1-antitrypsin and albumin in cystic fibrosis $131,000.00 2 year award
Paul Kubes The anti-inflammatory effects of Antithrombin III (AT III) in ischemia/repercussion injury $140,000.00 2 year award
David Lillicrap Strategies to enhance the development of a Gene Therapy approach to Hemophilia A $172,756.00 2 year award
Catherine Bergeron Lesion Profiling and glycoform analysis in Creutzfeldt-Jakob disease (CJD) $42,000.00 1 year award
John W. Semple In vivo effects of IVIG prepared from multiparous sera (IVIG MP) on modulating recipient alloimmunity $157,000.00 2 year award
David Westaway A transgenic approach to the molecular biology of Creutzfeldt-Jakob disease $160,000.00 2 year award
Thomas Ming Swi Chang Request for Renewal of Grant 9622R – Biodegradable Polymeric Hemoglobin Nanocapsules as a Blood Substitute $85,000.00 1 year award
Alan H. Lazarus Request for Renewal of Grant 9911 – Analysis of monoclonal human IVIG using a passive murine model of idiopathic thrombocytopenic purpura (ITP) $160,000.00 2 year award
Jean-François Hardy Treatment of Heparin Resistance with Antithrombin Concentrate in Patients Undergoing Myocardial Revascularization with Cardiopulmonary Bypass $59,000.00 1 year award
Ian D. Dubé Request for Renewal – Molecular genetic characterization of the inductive hematopoietic microenvironment $80,000.00 1 year award
Ori D. Rotstein Preconditioning using 25% Albumin: A Novel Method for Organ Protection in Ischemia-Reperfusion Injury $70,000.00 1 year award
Yu-Wen Hu The clinical consequence of high frequency of TT virus infection and re-infection in vulnerable blood transfusion or blood product dependent patients $80,000.00 1 year award
Donna A Chow IVIG Regulation of T Cell Activation $70,000.00 1 year award
Peter J. O’Brien Donor blood for cardiac surgery: hemebinding proteins may protect the heart $50,000.00 1 year award
Elisabeth Maurer-Spurej Heat shock treatment may induce stress tolerance in platelets for improved quality of platelet concentrates $45,000.00 1 year award
Gail A. Rock A study of the effects of using cryosupernatant plasma versus fresh frozen plasma as replacement fluid in plasma exchange for thrombotic thrombocytopenic purpura $25,000.00 1 year award
Sonia Néron Regulation of B lymphocyte functions by intravenous immunoglobulins (IVIG) $60,000.00 1 year award
Renée Bazin Study of the mechanism of action of intravenous immunoglobulin (IVIG) in an animal model $78,000.00 1 year award
Bruce Mazer Regulation of immune activation by intravenous immunoglobulin: Characterization of B lymphocyte activation, maturation and cytokine response $52,326.00 1 year award
Valery Leytin Optimization of dose for platelet transfusion: Adjustment in accordance with quality of platelets $76,000.00 1 year award
Eveline de Médicis Novel regulatory genes of erythropoiesis $140,000.00 2 year award
]

Top of the page [ Privacy and Access to Information | Terms of Use | Copyright © 1998-2014 Canadian Blood Services. All rights reserved.